nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—Etoposide—brain cancer	0.186	0.336	CbGbCtD
Triamcinolone—CYP3A4—Temozolomide—brain cancer	0.179	0.323	CbGbCtD
Triamcinolone—CYP3A4—Lomustine—brain cancer	0.152	0.275	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—brain cancer	0.0368	0.0664	CbGbCtD
Triamcinolone—Monoplegia—Carmustine—brain cancer	0.0136	0.0351	CcSEcCtD
Triamcinolone—Hyperadrenocorticism—Temozolomide—brain cancer	0.0132	0.0339	CcSEcCtD
Triamcinolone—Papilloedema—Procarbazine—brain cancer	0.0106	0.0273	CcSEcCtD
Triamcinolone—Blindness—Lomustine—brain cancer	0.0096	0.0247	CcSEcCtD
Triamcinolone—Cushing's syndrome—Carmustine—brain cancer	0.0093	0.0239	CcSEcCtD
Triamcinolone—Osteonecrosis—Procarbazine—brain cancer	0.00906	0.0233	CcSEcCtD
Triamcinolone—Skin atrophy—Hydroxyurea—brain cancer	0.00865	0.0222	CcSEcCtD
Triamcinolone—Atrophy—Hydroxyurea—brain cancer	0.00801	0.0206	CcSEcCtD
Triamcinolone—Throat sore—Lomustine—brain cancer	0.00737	0.019	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Lomustine—brain cancer	0.00731	0.0188	CcSEcCtD
Triamcinolone—Lupus erythematosus—Hydroxyurea—brain cancer	0.00701	0.018	CcSEcCtD
Triamcinolone—Fluocinonide—SMO—brain cancer	0.00641	0.907	CrCbGaD
Triamcinolone—Oropharyngeal pain—Lomustine—brain cancer	0.00584	0.015	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Procarbazine—brain cancer	0.00567	0.0146	CcSEcCtD
Triamcinolone—Optic neuritis—Procarbazine—brain cancer	0.00548	0.0141	CcSEcCtD
Triamcinolone—Meningitis—Carmustine—brain cancer	0.00544	0.014	CcSEcCtD
Triamcinolone—SERPINA6—hindbrain—brain cancer	0.00518	0.104	CbGeAlD
Triamcinolone—Intracranial pressure increased—Carmustine—brain cancer	0.00505	0.013	CcSEcCtD
Triamcinolone—Impaired healing—Carmustine—brain cancer	0.00488	0.0125	CcSEcCtD
Triamcinolone—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00472	0.0121	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.00439	0.0113	CcSEcCtD
Triamcinolone—Petechiae—Procarbazine—brain cancer	0.0041	0.0105	CcSEcCtD
Triamcinolone—Osteoarthritis—Lomustine—brain cancer	0.00386	0.00992	CcSEcCtD
Triamcinolone—Blister—Hydroxyurea—brain cancer	0.00362	0.00931	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Carmustine—brain cancer	0.00355	0.00912	CcSEcCtD
Triamcinolone—Embolism—Temozolomide—brain cancer	0.00318	0.00817	CcSEcCtD
Triamcinolone—Neuropathy—Procarbazine—brain cancer	0.00317	0.00814	CcSEcCtD
Triamcinolone—Tooth disorder—Temozolomide—brain cancer	0.00314	0.00809	CcSEcCtD
Triamcinolone—Myopathy—Temozolomide—brain cancer	0.00291	0.00748	CcSEcCtD
Triamcinolone—Ulcer—Hydroxyurea—brain cancer	0.00276	0.0071	CcSEcCtD
Triamcinolone—Vascular purpura—Procarbazine—brain cancer	0.00274	0.00704	CcSEcCtD
Triamcinolone—Haemoglobin—Lomustine—brain cancer	0.00268	0.0069	CcSEcCtD
Triamcinolone—Haemorrhage—Lomustine—brain cancer	0.00267	0.00686	CcSEcCtD
Triamcinolone—Abscess—Carmustine—brain cancer	0.00267	0.00686	CcSEcCtD
Triamcinolone—Optic neuritis—Etoposide—brain cancer	0.00265	0.00682	CcSEcCtD
Triamcinolone—Purpura—Procarbazine—brain cancer	0.00254	0.00653	CcSEcCtD
Triamcinolone—Skin exfoliation—Hydroxyurea—brain cancer	0.00249	0.00641	CcSEcCtD
Triamcinolone—Petechiae—Temozolomide—brain cancer	0.00248	0.00637	CcSEcCtD
Triamcinolone—Pulmonary oedema—Hydroxyurea—brain cancer	0.00232	0.00597	CcSEcCtD
Triamcinolone—NR3C1—hindbrain—brain cancer	0.00227	0.0456	CbGeAlD
Triamcinolone—PTGS2—endothelium—brain cancer	0.00223	0.0449	CbGeAlD
Triamcinolone—Infection—Carboplatin—brain cancer	0.00215	0.00553	CcSEcCtD
Triamcinolone—SERPINA6—pituitary gland—brain cancer	0.00214	0.0431	CbGeAlD
Triamcinolone—Pancreatitis—Procarbazine—brain cancer	0.00208	0.00534	CcSEcCtD
Triamcinolone—Sweating increased—Procarbazine—brain cancer	0.00206	0.0053	CcSEcCtD
Triamcinolone—PTGS2—blood vessel—brain cancer	0.00206	0.0414	CbGeAlD
Triamcinolone—Skin exfoliation—Carmustine—brain cancer	0.00201	0.00518	CcSEcCtD
Triamcinolone—Candida infection—Carmustine—brain cancer	0.00201	0.00518	CcSEcCtD
Triamcinolone—Dermatitis bullous—Hydroxyurea—brain cancer	0.00198	0.0051	CcSEcCtD
Triamcinolone—Neuropathy—Carmustine—brain cancer	0.00198	0.00509	CcSEcCtD
Triamcinolone—Candida infection—Temozolomide—brain cancer	0.00195	0.00501	CcSEcCtD
Triamcinolone—Skin exfoliation—Temozolomide—brain cancer	0.00195	0.00501	CcSEcCtD
Triamcinolone—Neuropathy—Temozolomide—brain cancer	0.00191	0.00492	CcSEcCtD
Triamcinolone—Infection—Lomustine—brain cancer	0.00188	0.00484	CcSEcCtD
Triamcinolone—Pain—Carboplatin—brain cancer	0.00185	0.00476	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Procarbazine—brain cancer	0.00185	0.00476	CcSEcCtD
Triamcinolone—Epistaxis—Procarbazine—brain cancer	0.00178	0.00458	CcSEcCtD
Triamcinolone—Thrombophlebitis—Carmustine—brain cancer	0.00177	0.00455	CcSEcCtD
Triamcinolone—Diabetes mellitus—Carmustine—brain cancer	0.00176	0.00453	CcSEcCtD
Triamcinolone—Ulcer—Etoposide—brain cancer	0.00173	0.00444	CcSEcCtD
Triamcinolone—Body temperature increased—Carboplatin—brain cancer	0.00171	0.0044	CcSEcCtD
Triamcinolone—Thrombophlebitis—Temozolomide—brain cancer	0.00171	0.0044	CcSEcCtD
Triamcinolone—Haemoglobin—Procarbazine—brain cancer	0.0017	0.00438	CcSEcCtD
Triamcinolone—Haemorrhage—Procarbazine—brain cancer	0.00169	0.00436	CcSEcCtD
Triamcinolone—Injury—Carmustine—brain cancer	0.00167	0.00429	CcSEcCtD
Triamcinolone—SERPINA6—endocrine gland—brain cancer	0.00166	0.0334	CbGeAlD
Triamcinolone—Vascular purpura—Temozolomide—brain cancer	0.00166	0.00426	CcSEcCtD
Triamcinolone—SERPINA6—head—brain cancer	0.00164	0.033	CbGeAlD
Triamcinolone—Pancreatitis—Hydroxyurea—brain cancer	0.00161	0.00413	CcSEcCtD
Triamcinolone—Candida infection—Etoposide—brain cancer	0.00156	0.00401	CcSEcCtD
Triamcinolone—Skin exfoliation—Etoposide—brain cancer	0.00156	0.00401	CcSEcCtD
Triamcinolone—Purpura—Temozolomide—brain cancer	0.00154	0.00395	CcSEcCtD
Triamcinolone—Neuropathy—Etoposide—brain cancer	0.00153	0.00394	CcSEcCtD
Triamcinolone—Arrhythmia—Procarbazine—brain cancer	0.00151	0.00389	CcSEcCtD
Triamcinolone—Body temperature increased—Lomustine—brain cancer	0.0015	0.00385	CcSEcCtD
Triamcinolone—SERPINA6—central nervous system—brain cancer	0.0015	0.0301	CbGeAlD
Triamcinolone—Weight increased—Hydroxyurea—brain cancer	0.00149	0.00383	CcSEcCtD
Triamcinolone—SERPINA6—cerebellum—brain cancer	0.00146	0.0294	CbGeAlD
Triamcinolone—BCHE—brainstem—brain cancer	0.00146	0.0294	CbGeAlD
Triamcinolone—Affect lability—Temozolomide—brain cancer	0.00146	0.00375	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Hydroxyurea—brain cancer	0.00143	0.00368	CcSEcCtD
Triamcinolone—Mood swings—Temozolomide—brain cancer	0.0014	0.00361	CcSEcCtD
Triamcinolone—Muscular weakness—Carmustine—brain cancer	0.00135	0.00347	CcSEcCtD
Triamcinolone—Syncope—Procarbazine—brain cancer	0.00132	0.0034	CcSEcCtD
Triamcinolone—Haemoglobin—Hydroxyurea—brain cancer	0.00132	0.00339	CcSEcCtD
Triamcinolone—Haemorrhage—Hydroxyurea—brain cancer	0.00131	0.00337	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Etoposide—brain cancer	0.00131	0.00336	CcSEcCtD
Triamcinolone—Muscular weakness—Temozolomide—brain cancer	0.00131	0.00336	CcSEcCtD
Triamcinolone—NR3C1—brainstem—brain cancer	0.0013	0.0262	CbGeAlD
Triamcinolone—Loss of consciousness—Procarbazine—brain cancer	0.0013	0.00333	CcSEcCtD
Triamcinolone—BCHE—telencephalon—brain cancer	0.0013	0.0261	CbGeAlD
Triamcinolone—Abdominal distension—Temozolomide—brain cancer	0.00129	0.00331	CcSEcCtD
Triamcinolone—Cough—Procarbazine—brain cancer	0.00129	0.00331	CcSEcCtD
Triamcinolone—Convulsion—Procarbazine—brain cancer	0.00128	0.00329	CcSEcCtD
Triamcinolone—Hypertension—Procarbazine—brain cancer	0.00127	0.00327	CcSEcCtD
Triamcinolone—Myalgia—Procarbazine—brain cancer	0.00126	0.00323	CcSEcCtD
Triamcinolone—Sweating increased—Temozolomide—brain cancer	0.00125	0.0032	CcSEcCtD
Triamcinolone—Bronchitis—Temozolomide—brain cancer	0.00123	0.00316	CcSEcCtD
Triamcinolone—Dry mouth—Procarbazine—brain cancer	0.00123	0.00316	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Etoposide—brain cancer	0.00122	0.00315	CcSEcCtD
Triamcinolone—Vomiting—Lomustine—brain cancer	0.00121	0.0031	CcSEcCtD
Triamcinolone—Oedema—Procarbazine—brain cancer	0.0012	0.00309	CcSEcCtD
Triamcinolone—Infection—Procarbazine—brain cancer	0.0012	0.00307	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Temozolomide—brain cancer	0.00119	0.00306	CcSEcCtD
Triamcinolone—SERPINA6—brain—brain cancer	0.00119	0.0239	CbGeAlD
Triamcinolone—Shock—Procarbazine—brain cancer	0.00118	0.00304	CcSEcCtD
Triamcinolone—Tachycardia—Procarbazine—brain cancer	0.00117	0.00302	CcSEcCtD
Triamcinolone—Weight increased—Temozolomide—brain cancer	0.00116	0.00299	CcSEcCtD
Triamcinolone—Hyperhidrosis—Procarbazine—brain cancer	0.00116	0.00299	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Carmustine—brain cancer	0.00116	0.00298	CcSEcCtD
Triamcinolone—NR3C1—telencephalon—brain cancer	0.00115	0.0232	CbGeAlD
Triamcinolone—Erythema—Hydroxyurea—brain cancer	0.00114	0.00293	CcSEcCtD
Triamcinolone—Cardiac arrest—Etoposide—brain cancer	0.00113	0.0029	CcSEcCtD
Triamcinolone—Nausea—Lomustine—brain cancer	0.00113	0.0029	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Temozolomide—brain cancer	0.00112	0.00288	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.0011	0.00282	CcSEcCtD
Triamcinolone—Insomnia—Procarbazine—brain cancer	0.00109	0.0028	CcSEcCtD
Triamcinolone—Paraesthesia—Procarbazine—brain cancer	0.00108	0.00278	CcSEcCtD
Triamcinolone—Haemoglobin—Carmustine—brain cancer	0.00107	0.00274	CcSEcCtD
Triamcinolone—Haemorrhage—Carmustine—brain cancer	0.00106	0.00273	CcSEcCtD
Triamcinolone—Ill-defined disorder—Hydroxyurea—brain cancer	0.00106	0.00272	CcSEcCtD
Triamcinolone—BCHE—pituitary gland—brain cancer	0.00106	0.0212	CbGeAlD
Triamcinolone—Fatigue—Procarbazine—brain cancer	0.00104	0.00267	CcSEcCtD
Triamcinolone—Haemoglobin—Temozolomide—brain cancer	0.00103	0.00265	CcSEcCtD
Triamcinolone—Malaise—Hydroxyurea—brain cancer	0.00103	0.00265	CcSEcCtD
Triamcinolone—Pain—Procarbazine—brain cancer	0.00103	0.00265	CcSEcCtD
Triamcinolone—Haemorrhage—Temozolomide—brain cancer	0.00102	0.00263	CcSEcCtD
Triamcinolone—BCHE—medulla oblongata—brain cancer	0.00102	0.0205	CbGeAlD
Triamcinolone—Pharyngitis—Temozolomide—brain cancer	0.00102	0.00261	CcSEcCtD
Triamcinolone—PTGS2—telencephalon—brain cancer	0.000999	0.0201	CbGeAlD
Triamcinolone—Sweating increased—Etoposide—brain cancer	0.000997	0.00256	CcSEcCtD
Triamcinolone—Feeling abnormal—Procarbazine—brain cancer	0.000992	0.00255	CcSEcCtD
Triamcinolone—Convulsion—Hydroxyurea—brain cancer	0.000989	0.00254	CcSEcCtD
Triamcinolone—NR3C1—gonad—brain cancer	0.000963	0.0194	CbGeAlD
Triamcinolone—Discomfort—Hydroxyurea—brain cancer	0.00096	0.00247	CcSEcCtD
Triamcinolone—Urticaria—Procarbazine—brain cancer	0.000956	0.00246	CcSEcCtD
Triamcinolone—Body temperature increased—Procarbazine—brain cancer	0.000951	0.00245	CcSEcCtD
Triamcinolone—Arrhythmia—Carmustine—brain cancer	0.000947	0.00243	CcSEcCtD
Triamcinolone—NR3C1—pituitary gland—brain cancer	0.000939	0.0189	CbGeAlD
Triamcinolone—Oedema—Hydroxyurea—brain cancer	0.000931	0.00239	CcSEcCtD
Triamcinolone—BCHE—midbrain—brain cancer	0.000931	0.0187	CbGeAlD
Triamcinolone—Infection—Hydroxyurea—brain cancer	0.000925	0.00238	CcSEcCtD
Triamcinolone—Erythema—Carmustine—brain cancer	0.000923	0.00237	CcSEcCtD
Triamcinolone—BCHE—spinal cord—brain cancer	0.000908	0.0183	CbGeAlD
Triamcinolone—NR3C1—medulla oblongata—brain cancer	0.000907	0.0182	CbGeAlD
Triamcinolone—Acute coronary syndrome—Etoposide—brain cancer	0.0009	0.00231	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Etoposide—brain cancer	0.000895	0.0023	CcSEcCtD
Triamcinolone—Myocardial infarction—Etoposide—brain cancer	0.000895	0.0023	CcSEcCtD
Triamcinolone—Back pain—Carmustine—brain cancer	0.000892	0.00229	CcSEcCtD
Triamcinolone—Erythema—Temozolomide—brain cancer	0.000892	0.00229	CcSEcCtD
Triamcinolone—Hypersensitivity—Procarbazine—brain cancer	0.000887	0.00228	CcSEcCtD
Triamcinolone—Dysgeusia—Temozolomide—brain cancer	0.000873	0.00224	CcSEcCtD
Triamcinolone—Asthenia—Procarbazine—brain cancer	0.000864	0.00222	CcSEcCtD
Triamcinolone—Back pain—Temozolomide—brain cancer	0.000862	0.00222	CcSEcCtD
Triamcinolone—Pruritus—Procarbazine—brain cancer	0.000851	0.00219	CcSEcCtD
Triamcinolone—Dyspnoea—Hydroxyurea—brain cancer	0.00083	0.00214	CcSEcCtD
Triamcinolone—NR3C1—midbrain—brain cancer	0.000829	0.0167	CbGeAlD
Triamcinolone—Ill-defined disorder—Temozolomide—brain cancer	0.000827	0.00213	CcSEcCtD
Triamcinolone—Dyspepsia—Hydroxyurea—brain cancer	0.00082	0.00211	CcSEcCtD
Triamcinolone—BCHE—endocrine gland—brain cancer	0.000818	0.0164	CbGeAlD
Triamcinolone—Angioedema—Temozolomide—brain cancer	0.000815	0.00209	CcSEcCtD
Triamcinolone—PTGS2—pituitary gland—brain cancer	0.000813	0.0164	CbGeAlD
Triamcinolone—NR3C1—spinal cord—brain cancer	0.000808	0.0163	CbGeAlD
Triamcinolone—BCHE—head—brain cancer	0.000807	0.0162	CbGeAlD
Triamcinolone—Malaise—Temozolomide—brain cancer	0.000804	0.00207	CcSEcCtD
Triamcinolone—Fatigue—Hydroxyurea—brain cancer	0.000803	0.00206	CcSEcCtD
Triamcinolone—Vertigo—Temozolomide—brain cancer	0.000801	0.00206	CcSEcCtD
Triamcinolone—Convulsion—Carmustine—brain cancer	0.000799	0.00206	CcSEcCtD
Triamcinolone—Hypertension—Carmustine—brain cancer	0.000797	0.00205	CcSEcCtD
Triamcinolone—Pain—Hydroxyurea—brain cancer	0.000797	0.00205	CcSEcCtD
Triamcinolone—Dizziness—Procarbazine—brain cancer	0.000796	0.00205	CcSEcCtD
Triamcinolone—Myalgia—Carmustine—brain cancer	0.000785	0.00202	CcSEcCtD
Triamcinolone—PTGS2—medulla oblongata—brain cancer	0.000785	0.0158	CbGeAlD
Triamcinolone—Cough—Temozolomide—brain cancer	0.000778	0.002	CcSEcCtD
Triamcinolone—Convulsion—Temozolomide—brain cancer	0.000772	0.00199	CcSEcCtD
Triamcinolone—Hypertension—Temozolomide—brain cancer	0.00077	0.00198	CcSEcCtD
Triamcinolone—Feeling abnormal—Hydroxyurea—brain cancer	0.000768	0.00197	CcSEcCtD
Triamcinolone—Vomiting—Procarbazine—brain cancer	0.000765	0.00197	CcSEcCtD
Triamcinolone—Myalgia—Temozolomide—brain cancer	0.000759	0.00195	CcSEcCtD
Triamcinolone—Rash—Procarbazine—brain cancer	0.000759	0.00195	CcSEcCtD
Triamcinolone—Dermatitis—Procarbazine—brain cancer	0.000758	0.00195	CcSEcCtD
Triamcinolone—Headache—Procarbazine—brain cancer	0.000754	0.00194	CcSEcCtD
Triamcinolone—Oedema—Carmustine—brain cancer	0.000753	0.00194	CcSEcCtD
Triamcinolone—Discomfort—Temozolomide—brain cancer	0.00075	0.00193	CcSEcCtD
Triamcinolone—Infection—Carmustine—brain cancer	0.000748	0.00192	CcSEcCtD
Triamcinolone—Dry mouth—Temozolomide—brain cancer	0.000742	0.00191	CcSEcCtD
Triamcinolone—BCHE—central nervous system—brain cancer	0.000737	0.0148	CbGeAlD
Triamcinolone—Body temperature increased—Hydroxyurea—brain cancer	0.000736	0.00189	CcSEcCtD
Triamcinolone—Tachycardia—Carmustine—brain cancer	0.000735	0.00189	CcSEcCtD
Triamcinolone—NR3C1—endocrine gland—brain cancer	0.000728	0.0146	CbGeAlD
Triamcinolone—Oedema—Temozolomide—brain cancer	0.000728	0.00187	CcSEcCtD
Triamcinolone—Anaphylactic shock—Temozolomide—brain cancer	0.000728	0.00187	CcSEcCtD
Triamcinolone—Infection—Temozolomide—brain cancer	0.000723	0.00186	CcSEcCtD
Triamcinolone—BCHE—cerebellum—brain cancer	0.00072	0.0145	CbGeAlD
Triamcinolone—NR3C1—head—brain cancer	0.000718	0.0145	CbGeAlD
Triamcinolone—PTGS2—midbrain—brain cancer	0.000717	0.0144	CbGeAlD
Triamcinolone—Nausea—Procarbazine—brain cancer	0.000715	0.00184	CcSEcCtD
Triamcinolone—Hyperhidrosis—Temozolomide—brain cancer	0.000703	0.00181	CcSEcCtD
Triamcinolone—PTGS2—spinal cord—brain cancer	0.0007	0.0141	CbGeAlD
Triamcinolone—Dysgeusia—Etoposide—brain cancer	0.000699	0.0018	CcSEcCtD
Triamcinolone—Back pain—Etoposide—brain cancer	0.00069	0.00177	CcSEcCtD
Triamcinolone—Hypersensitivity—Hydroxyurea—brain cancer	0.000686	0.00176	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000686	0.00176	CcSEcCtD
Triamcinolone—Insomnia—Carmustine—brain cancer	0.000681	0.00175	CcSEcCtD
Triamcinolone—Paraesthesia—Carmustine—brain cancer	0.000676	0.00174	CcSEcCtD
Triamcinolone—Dyspnoea—Carmustine—brain cancer	0.000671	0.00173	CcSEcCtD
Triamcinolone—Asthenia—Hydroxyurea—brain cancer	0.000668	0.00172	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000663	0.0017	CcSEcCtD
Triamcinolone—Ill-defined disorder—Etoposide—brain cancer	0.000662	0.0017	CcSEcCtD
Triamcinolone—Dexamethasone—CYP2C9—brain cancer	0.000661	0.0935	CrCbGaD
Triamcinolone—Insomnia—Temozolomide—brain cancer	0.000658	0.00169	CcSEcCtD
Triamcinolone—NR3C1—central nervous system—brain cancer	0.000656	0.0132	CbGeAlD
Triamcinolone—Paraesthesia—Temozolomide—brain cancer	0.000653	0.00168	CcSEcCtD
Triamcinolone—Dyspnoea—Temozolomide—brain cancer	0.000649	0.00167	CcSEcCtD
Triamcinolone—Pain—Carmustine—brain cancer	0.000644	0.00166	CcSEcCtD
Triamcinolone—Malaise—Etoposide—brain cancer	0.000643	0.00165	CcSEcCtD
Triamcinolone—NR3C1—cerebellum—brain cancer	0.000641	0.0129	CbGeAlD
Triamcinolone—Vertigo—Etoposide—brain cancer	0.000641	0.00165	CcSEcCtD
Triamcinolone—Dyspepsia—Temozolomide—brain cancer	0.000641	0.00165	CcSEcCtD
Triamcinolone—PTGS2—endocrine gland—brain cancer	0.00063	0.0127	CbGeAlD
Triamcinolone—Fatigue—Temozolomide—brain cancer	0.000627	0.00161	CcSEcCtD
Triamcinolone—Loss of consciousness—Etoposide—brain cancer	0.000627	0.00161	CcSEcCtD
Triamcinolone—Cough—Etoposide—brain cancer	0.000623	0.0016	CcSEcCtD
Triamcinolone—Pain—Temozolomide—brain cancer	0.000622	0.0016	CcSEcCtD
Triamcinolone—PTGS2—head—brain cancer	0.000622	0.0125	CbGeAlD
Triamcinolone—Feeling abnormal—Carmustine—brain cancer	0.00062	0.0016	CcSEcCtD
Triamcinolone—Convulsion—Etoposide—brain cancer	0.000618	0.00159	CcSEcCtD
Triamcinolone—Hypertension—Etoposide—brain cancer	0.000616	0.00158	CcSEcCtD
Triamcinolone—Dizziness—Hydroxyurea—brain cancer	0.000616	0.00158	CcSEcCtD
Triamcinolone—Discomfort—Etoposide—brain cancer	0.0006	0.00154	CcSEcCtD
Triamcinolone—Feeling abnormal—Temozolomide—brain cancer	0.0006	0.00154	CcSEcCtD
Triamcinolone—Body temperature increased—Carmustine—brain cancer	0.000595	0.00153	CcSEcCtD
Triamcinolone—Vomiting—Hydroxyurea—brain cancer	0.000592	0.00152	CcSEcCtD
Triamcinolone—Rash—Hydroxyurea—brain cancer	0.000587	0.00151	CcSEcCtD
Triamcinolone—Dermatitis—Hydroxyurea—brain cancer	0.000587	0.00151	CcSEcCtD
Triamcinolone—BCHE—brain—brain cancer	0.000585	0.0118	CbGeAlD
Triamcinolone—Headache—Hydroxyurea—brain cancer	0.000584	0.0015	CcSEcCtD
Triamcinolone—Anaphylactic shock—Etoposide—brain cancer	0.000582	0.0015	CcSEcCtD
Triamcinolone—Infection—Etoposide—brain cancer	0.000578	0.00149	CcSEcCtD
Triamcinolone—Urticaria—Temozolomide—brain cancer	0.000578	0.00149	CcSEcCtD
Triamcinolone—Body temperature increased—Temozolomide—brain cancer	0.000575	0.00148	CcSEcCtD
Triamcinolone—Tachycardia—Etoposide—brain cancer	0.000568	0.00146	CcSEcCtD
Triamcinolone—PTGS2—central nervous system—brain cancer	0.000568	0.0114	CbGeAlD
Triamcinolone—Hyperhidrosis—Etoposide—brain cancer	0.000563	0.00145	CcSEcCtD
Triamcinolone—Hypersensitivity—Carmustine—brain cancer	0.000555	0.00143	CcSEcCtD
Triamcinolone—PTGS2—cerebellum—brain cancer	0.000555	0.0112	CbGeAlD
Triamcinolone—Nausea—Hydroxyurea—brain cancer	0.000553	0.00142	CcSEcCtD
Triamcinolone—CYP3A4—endocrine gland—brain cancer	0.00055	0.0111	CbGeAlD
Triamcinolone—Asthenia—Carmustine—brain cancer	0.00054	0.00139	CcSEcCtD
Triamcinolone—Hypersensitivity—Temozolomide—brain cancer	0.000536	0.00138	CcSEcCtD
Triamcinolone—Paraesthesia—Etoposide—brain cancer	0.000523	0.00134	CcSEcCtD
Triamcinolone—Asthenia—Temozolomide—brain cancer	0.000522	0.00134	CcSEcCtD
Triamcinolone—NR3C1—brain—brain cancer	0.000521	0.0105	CbGeAlD
Triamcinolone—Dyspnoea—Etoposide—brain cancer	0.000519	0.00133	CcSEcCtD
Triamcinolone—Pruritus—Temozolomide—brain cancer	0.000515	0.00132	CcSEcCtD
Triamcinolone—Fatigue—Etoposide—brain cancer	0.000502	0.00129	CcSEcCtD
Triamcinolone—Dizziness—Carmustine—brain cancer	0.000498	0.00128	CcSEcCtD
Triamcinolone—Pain—Etoposide—brain cancer	0.000498	0.00128	CcSEcCtD
Triamcinolone—CYP3A4—central nervous system—brain cancer	0.000496	0.00998	CbGeAlD
Triamcinolone—Dizziness—Temozolomide—brain cancer	0.000481	0.00124	CcSEcCtD
Triamcinolone—Feeling abnormal—Etoposide—brain cancer	0.00048	0.00123	CcSEcCtD
Triamcinolone—Vomiting—Carmustine—brain cancer	0.000479	0.00123	CcSEcCtD
Triamcinolone—Rash—Carmustine—brain cancer	0.000475	0.00122	CcSEcCtD
Triamcinolone—Dermatitis—Carmustine—brain cancer	0.000474	0.00122	CcSEcCtD
Triamcinolone—Headache—Carmustine—brain cancer	0.000472	0.00121	CcSEcCtD
Triamcinolone—Vomiting—Temozolomide—brain cancer	0.000463	0.00119	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—brain cancer	0.000463	0.00119	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—brain cancer	0.00046	0.00118	CcSEcCtD
Triamcinolone—Rash—Temozolomide—brain cancer	0.000459	0.00118	CcSEcCtD
Triamcinolone—Dermatitis—Temozolomide—brain cancer	0.000458	0.00118	CcSEcCtD
Triamcinolone—Headache—Temozolomide—brain cancer	0.000456	0.00117	CcSEcCtD
Triamcinolone—PTGS2—brain—brain cancer	0.000451	0.00906	CbGeAlD
Triamcinolone—Nausea—Carmustine—brain cancer	0.000447	0.00115	CcSEcCtD
Triamcinolone—Nausea—Temozolomide—brain cancer	0.000432	0.00111	CcSEcCtD
Triamcinolone—Hypersensitivity—Etoposide—brain cancer	0.000429	0.0011	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—brain cancer	0.000418	0.00107	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—brain cancer	0.000412	0.00106	CcSEcCtD
Triamcinolone—Dizziness—Etoposide—brain cancer	0.000385	0.00099	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—brain cancer	0.00037	0.000952	CcSEcCtD
Triamcinolone—Rash—Etoposide—brain cancer	0.000367	0.000944	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—brain cancer	0.000367	0.000943	CcSEcCtD
Triamcinolone—Headache—Etoposide—brain cancer	0.000365	0.000938	CcSEcCtD
Triamcinolone—Nausea—Etoposide—brain cancer	0.000346	0.000889	CcSEcCtD
